NCT04984603

Brief Summary

Peripheral Veno-Arterial Extra Corporeal Membrane Oxygenation (VA ECMO) is a temporary assistance that provides a mechanical circulatory support in patients victim of cardiogenic shock (CS) or refractory cardiac arrest. During VA-ECMO support, hypotension may frequently occur due to deteriorated cardiac function, vasoplegia, or hypovolemia. Volume expansion is a common means to correct hypotension and improve systemic perfusion, but inappropriate fluid therapy is associated with adverse outcomes. As other intensive care unit (ICU) patients, VA-ECMO assisted patients have been shown to have higher mortality in case of large early fluid administration. Prediction of fluid responsiveness could achieve a lower fluid balance and improve outcomes of patients treated with VA-ECMO. Several dynamic hemodynamic parameters based on cardio-pulmonary interactions (stroke volume, pulse pressure or inferior vena cava variations induced by invasive ventilation cycles) have been described and validated for predicting fluid responsiveness in critically ill patients. Unfortunately, the VA-ECMO conditions (native cardiac circulation by-pass, low pulsatility, presence of drainage canulation in the inferior vena cava, the use of low tidal volume) make this parameters less reliable. Simulation of a fluid loading by shifting blood from the lower limbs and splanchnic compartment thanks to a revisable maneuver is another feasible approach to assess fluid responsiveness. Whereas the use of different maneuvers have been validated in the classical ICU population, very few data exist in the ECMO population and their application is questioning because blood transfer may be modified by the preload dependence of the ECMO. Recently, Luo et al showed that the variation of aortic Velocity Time Integral (VTI) measured using echocardiography induced by a Trendelenburg maneuver was predictive of fluid responsiveness during VA-ECMO support. However, their study excluded patients with low cardiac ejection (pulse pressure \< 15 mmHg) so that their data may not be extrapolated to the acute phase of heart failure requiring full mechanical support. Moreover, aortic VTI measurement suffers from low reproducibility in case of low native cardiac output (NCO) and arrythmia; and can be time-consuming. The investigators previously demonstrated in an observational prospective study that End-tidal CO2 (EtCO2) and Pulse Pressure (PP) were strongly correlated to NCO during VA-ECMO when NCO \< 2l/min. The investigators aim to study the variations of aortic VTI, EtCO2 and PP induced by Passive Leg Rising (PLR) and their ability to predict fluid responsiveness in patients under VA-ECMO.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

June 30, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 30, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

November 15, 2021

Status Verified

November 1, 2021

Enrollment Period

1.6 years

First QC Date

June 30, 2021

Last Update Submit

November 12, 2021

Conditions

Keywords

Adults humanProspective studyCardiogenic shockPeripheral veno-arterial extracorporeal membrane oxygenationFluid responsivenessPassive leg raisingNative cardiac outputEnd-tidal carbon dioxide

Outcome Measures

Primary Outcomes (1)

  • Correlation between VTI changes induced by PLR and VTI changes induced by fluid challenge

    VTI variations induced by PLR vs VTI variations induced by fluid challenge

    During VA-ECMO support (<28 days)

Secondary Outcomes (2)

  • Correlation between EtCO2 changes induced by PLR and EtCO2 changes induced by fluid challenge

    During VA-ECMO support (<28 days)

  • Correlation between PP changes induced by PLR and PP changes induced by fluid challenge

    During VA-ECMO support (<28 days)

Interventions

After securing the VA-ECMO tubing, PLR is realized using an automatic bed elevation technique. The lower limbs are raised to a 45° angle while the patient's trunk is lowered in supine position

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients under invasive mechanical ventilation and VA-ECMO support with indication of vascular expansion

You may qualify if:

  • Decision to perform volume expansion made by the attending physician for one of the following reasons:
  • Hypotension or attempt to reduce vasopressor dose
  • Hypoperfusion (oliguria, skin mottling, hyperlactatemia)
  • Suspected Low NCO

You may not qualify if:

  • Age less than 18 years
  • Evidence of significant hypovolemia such as kicking drainage cannula
  • Active hemorrhage
  • Concomitant left ventricle assist device (Impella/ LVAD) or Intra-aortic balloon pump (IABP)
  • Atrial or ventricular communication
  • Significant aortic insufficiency
  • Unsatisfactory cardiac echogenicity (an inability to correctly align the Doppler beam to generate reliable VTI measurements at the left ventricular outflow tract (LVOT)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Shock, Cardiogenic

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisShock

Study Officials

  • MARC MOURAD, MD

    University Hospital, Montpellier

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 30, 2021

First Posted

July 30, 2021

Study Start

February 1, 2020

Primary Completion

September 1, 2021

Study Completion

June 1, 2022

Last Updated

November 15, 2021

Record last verified: 2021-11

Locations